This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody & ADC Summit At ChinaBio
Shanghai, China
Kerry Hotel Pudong, Shanghai, ChinaApril 28–29, 2026

Dr. Alfredo Quijano Rubio, PhD
Co-founder and Chief Scientific Officer at Monod Bio
Speaker

Profile

Alfredo Quijano Rubio is a scientist and entrepreneur specializing in computational protein design. He is the co-founder and Chief Scientific Officer (CSO) of Monod Bio, a company pioneering the design of novel diagnostics and research reagents using AI-powered computational protein design. He obtained a Ph.D. in Bioengineering at the University of Washington under the mentorship of Professor David Baker, Nobel Prize in Chemistry in 2024. His research on designing conditionally-active proteins for immunotherapy and biosensors resulted in high-impact scientific publications, patents, and the creation of two companies: Neoleukin Therapeutics and Monod Bio. Alfredo has been recognized by Business Insider and by the Puget Sound Business Journal as one of the young leaders revolutionizing the healthtech sector.